NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

" Perhaps, it was referred to the CHM to consider all solid tumors...That is what I believe and I will certainly get ridiculed for it"

Not ridiculous at all but more likely that we will first be approved only for GBM and glioma III.
Thereafter we will need many flaskworks units because without them, the demand coming from
the huge number of patients with various types of solid tumors, cannot be met. Since installation,
testing and certification of the many flaskworks units will take a long time, my hunch is that
approval may be first limited to GBM and glioma III patients and sometime thereafter many other
solid tumors will come into play.